RA Capital Management L.P., a prominent investment firm, executed a significant transaction by acquiring an additional 1,577,341 shares of Janux Therapeutics Inc (NASDAQ:JANX). This move not only ...

We feel now is a pretty good time to analyse Anavex Life Sciences Corp.'s ( NASDAQ:AVXL ) business as it appears ...

Kintara Therapeutics, Inc., a clinical stage drug ... non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of ...

With every major advancement in the field of aging biology, humankind is one step closer to turning back the clock and restoring our youth. In ...

In Type 1 diabetes (T1D), insulin-producing β-cells are killed by islet-infiltrating immune cells in a process called “insulitis”. T1D results in a critical requirement for exogenous insulin and ...

Here the authors show that the N1-methylpseudouridine (m1ψ), used in therapeutics ... show that self-aminoacylating D-RNAs do not have an intrinsic preference for L-amino acids, suggesting ...

To decide if stock is a buy or sell, you’ll want to evaluate its fair market price or intrinsic value. Buying stocks that are going to go up typically means buying stocks that are undervalued in the ...

View the VKTX option chain and compare options of Viking Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell ...

View the PTCT option chain and compare options of PTC Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell ...

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...